Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort.

Thomas G Martin, María-Victoria Mateos, Jun Ho Yi, Niels W C J van de Donk, Zhen Cai, Weijun Fu, Alfred L Garfall, Shinsuke Iida, Sung-Hoon Jung, Yoshiaki Kuroda, Ting Niu, Ajay K Nooka, Chang-Ki Min, Surbhi Sidana, Katherine Chastain